General

Good news from Cartherics. The company’s off-the-shelf immune therapy for ovarian cancer is close to clinical trials

View the article in the CRC (Cooperative Research Centres Association) Association Newsletter here : CRC Association Newsletter

Cartherics’ cost-effective ‘off-the-shelf’ ovarian cancer therapy made from special donor umbilical cord blood samples is in the final stages of preclinical development.

By combining immunotherapy and stem cell research, we can manufacture Natural Killer (NK) cells that carry a […]

2020-09-23T05:36:40+00:00September 23rd, 2020|

Frustrated by Victoria’s COVID-19 Lockdown? Try India ……

That’s where Anisha Balachandran – Cartherics’ past PhD student has been since January

22 September 2020

Finally, Anisha is back, well almost. She is currently in lockdown in Sydney. While there, she spoke with Cartherics Communication’s Advisor Leigh Dayton about her experience.

When and why did you go to India?

My dad passed away due to a cardiac arrest […]

2020-09-22T06:41:02+00:00September 22nd, 2020|

Cartherics CEO Alan Trounson celebrates 40 years of the GSK Award for Excellence

Along with others Alan shares his experience in this short clip  ………

 

 

 

2020-09-08T02:41:33+00:00September 8th, 2020|

From waging war with elusive pathogens to tackling cancer

Cartherics’ newest recruit, Phil Arandjelovic loves it all

By Leigh Dayton

In his application for Cartherics’ Research Scientist position, Phil noted: “I am an independent and hard-working research scientist who is proficient at working both individually and with a team”. True.

What Phil failed to mention is that he loves a good conversation. Politics, mentoring, economics and, of […]

2020-09-07T05:26:42+00:00September 7th, 2020|

The answer to self-discovery is found at Cartherics

For new recruit Walid Azar, it was about finding his calling.

 As Walid Azar settles into his new dual role as Senior Research Fellow and Deputy Lab Manager at Cartherics, he feels content that he has finally found his calling. With previous experience in both cancer research and industry, he acknowledges having lived in the best […]

2020-09-02T02:45:37+00:00September 2nd, 2020|

‘Chance favours the prepared mind’

Frederico Calhabeu has followed Louis Pasteur’s advice from France to Cartherics

By Leigh Dayton

When considering whether to continue his translational research program at the Australian Regenerative Medicine Institute (ARMI), Frederico Calhabeu had a quick chat with Silvio Tiziani, Director, External Strategy and Planning at ARMI.

Silvio suggested a quiet word with several contacts in the […]

2020-08-27T00:48:45+00:00August 27th, 2020|

Celebrating National Science Week / Q&A with Dr Ian Nisbet – Cartherics’ COO

In celebration of National Science Week 2020, Solubility is supporting the#InspiringAustraliaInitiative by profiling five dynamic scientific careers.

Next up in our daily interview series is Dr Ian Nisbet.


What does your role entail?

Cartherics is harnessing the body’s immune system to target and kill cancer […]

2020-08-19T23:44:57+00:00August 19th, 2020|

Good News from Cartherics

New funding from the Federal Entrepreneurs Programme will boost the company’s R&D efforts

By Leigh Dayton

“It’s good to get new money into Cartherics,” says the Cartherics’ Chief Scientific Officer Richard Boyd. He adds that the AU$120,000 in grant funding is particularly welcome as all Melbourne-based research and development (R&D) groups are managing the hurdles of […]

2020-08-19T06:21:41+00:00August 19th, 2020|

Cartherics attends international meeting of cell therapy leaders – virtually.

Join a panel on “off-the-shelf” therapies with CEO Alan Trounson

By Leigh Dayton

8 July 2020

Cartherics will take part in the Onco Cell Therapy Summit 2020 virtual conference 8-10 July AEST. Cartherics CEO Alan Trounson, Chief Scientific Officer Richard Boyd and lead scientists will join an international gathering of key decision makers for CAR-T therapies.

The Summit, […]

2020-07-08T03:35:28+00:00July 8th, 2020|

What’s COVID-19 doing to Australian Biotech ?

Cartherics Chief Scientific Officer Richard Boyd and Chief Operating Officer Ian Nisbet take a hard look

It’s hardly news. COVID-19 is a global threat. By the end of May 2020 it had killed 356,000 people worldwide and 103 Australians. The cost to the global economy is estimated in the trillions of dollars and Governments around the […]

2020-06-04T04:44:25+00:00June 4th, 2020|